<DOC>
	<DOCNO>NCT00115453</DOCNO>
	<brief_summary>Boron Neutron Capture Therapy ( BNCT ) experimental radiation therapy technique base principle irradiate boron atom neutron . When neutron relatively low energy , boron atom target cancerous tissue use suitable boron carrier ( amino acid derivative call BPA , boronophenylalanine ) capture neutron . As result neutron capture boron atom split two , produce helium lithium ion . The helium lithium ion , turn , short pathlength tissue ( 5 micrometer ) deposit cell damage effect mainly within tumor provide boron carrier ( BPA ) accumulate tumor . In practice , study participant receive BPA approximately 2-hour intravenous infusion , follow tumor irradiate low energy ( epithermal ) neutron obtain nuclear reactor BNCT facility . BNCT require careful radiation dose planning , neutron irradiation last approximately one hour . In study BNCT give . The study hypothesis glioblastoma tissue may accumulate boron carrier compound , glioblastoma might respond BNCT .</brief_summary>
	<brief_title>Boron Neutron Capture Therapy ( BNCT ) Treatment Glioblastoma</brief_title>
	<detailed_description>This single BNCT-facility , non-randomized , non-comparative , prospective , open-label , phase I/II trial determine value BNCT treatment subject undergone surgery glioblastoma , glioblastoma treat radiation therapy chemotherapy . The neutron irradiation site FiR 1 reactor site , locate Otaniemi , Espoo , Finland , 6 kilometer Helsinki University Central Hospital , Helsinki , patient evaluation post-irradiation care take place . BPA infuse fructose complex ( BPA-F ) peripheral vein 2 hour prior neutron irradiation . Blood sample take start BPA infusion , thereafter 20 40 minute interval infusion , follow infusion , deliver neutron irradiation monitor blood boron concentration . The blood sample analyze boron estimate average blood boron level neutron irradiation . The first 12 patient treat use BPA dose 290 mg/kg , follow dose BPA increase stepwise 500 mg/kg , provide unacceptable toxicity occur . All patient evaluate response use CT magnetic resonance imaging ( MRI ) .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Boron</mesh_term>
	<criteria>Histologically confirm glioblastoma multiforme Supratentorial location At least 30 % tumor volume remove craniotomy judge pre/perioperative MRI Ability understand concept investigational therapy Tolerates dexamethasone treatment Adequate antiepileptic medication BNCT deliver within 6 week date brain surgery A write informed consent Age le 18 great 75 The tumor infiltrate optic chiasm deep part brain prohibiting delivery adequate radiation dose BNCT Prior radiation therapy brain Prior chemotherapy , immunotherapy , gene therapy Karnofsky performance score &lt; 70 Severe cardiac , liver , kidney failure Severe infection A cardiac pacemaker , metal implant head neck region prohibit MRI examination Pregnancy lactation Phenylketonuria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>glioblastoma</keyword>
	<keyword>boron neutron capture therapy</keyword>
	<keyword>boronophenylalanine</keyword>
	<keyword>brain tumor</keyword>
</DOC>